Skip to main content
. 2018 Feb 5;98(4):1186–1193. doi: 10.4269/ajtmh.17-0090

Table 2.

Characteristics of survivors and nonsurvivors

Characteristic Survivors N = 11 Nonsurvivors N = 42 Unadjusted OR (95% CI) P value Adjusted OR (95% CI) P value
Median age (IQR) 40 (23–43) 35 (29.8–48.2) 0.63
Male:female ratio 1.8:1 1.9:1 1.1 (0.2–5.3) 1 1.0 (0.2–4.8) 1
Health-care worker 4/11 (36.4%) 14/41 (34.1%) 0.9 (0.2–5.0) 1 1.0 (0.2–6.2) 1
Median duration of hospitalization in days (IQR) 17 (13.5–20.5) 4 (2.3–6) 3 × 10−6
Duration of hospitalization > 10 days* 9/11 (81.8%) 1/42 (2.4%) 136 (12–7,650) 1 × 10−7 124 (10.6–7,380) 2 × 10−7
Median days (IQR) between symptom onset and admission 4.5 (2.3–6.8)) 5 (3–7) 0.67
Signs and symptoms
 Weakness 8/9 (88.9%) 32/35 (91.4%) 1.3 (0.0–19.3) 1 1.0 (0.0–16) 1
 Fever 8/11 (72.7%) 31/37 (83.7%) 1.9 (0.3–11.6) 0.41 1.8 (0.2–10.5) 0.67
 Diarrhea 2/9 (22.2%) 33/36 (91.7%) 32.8 (4.1–464) 8 × 10−5 26.1 (3.5–332) 2 × 10−4
 Nausea 6/9 (66.7%) 26/36 (72.2) 1.3 (0.2–7.6) 0.7 1.3 (0.2–7.8) 0.7
 Vomiting 4/9 (44.4%) 23/36 (63.9%) 2.2 (0.4–13.1) 0.45 2.1 (0.4–12.7) 0.45
 Abdominal pain 4/9 (44.4%) 18/32 (56.2%) 1.6 (0.3–9.6) 0.71 1.42 (0.2–8.8) 0.72
 Headache 3/8 (37.5%) 18/32 (56.2%) 2.1 (0.3–15.9) 0.44 2.4 (0.4–17.7) 0.43
Hemorrhagic symptoms:
 Visible 0/10 (0%) 11/34 (32.4%) 0.046 0.041
 Subconjunctival 0/10 (0%) 13/34 (38.2%) 0.021 0.019
 Combined 0/10 (0%) 17/34 (50.0%) 3.7 × 10−3 2.9 × 10−3
 Respiratory distress 2/10 (20%) 7/34 (20.6%) 1.0 (0.2–12.2) 1 1.1 (0.2–12.8) 1
 Hiccups 0/10 (0%) 2/34 (5.9%) 1 1
Vital signs
 Median temperature (°C) on admission (IQR) 38 (37–38.6) 37.2 (36.8–37.9) 0.26
 Median maximum temperature (°C) during admission (IQR) 38.4 (38–39.2) 38.6 (38–39.4) 0.81
 Median admission heart rate (IQR) (beats per minute) 77 (70–84) 88 (82–102) 0.1
 Median admission respiratory rate (IQR) (breaths per minute) 27 (25–30) 22 (20–27) 0.23

CI = confidence interval; IQR = interquartile range; OR = odds ratio.

*

10 days is the midpoint in the median duration of hospitalization between those who died and those who survived.

Visible hemorrhagic symptoms refer to active bleeding from one or more sites; subconjunctival refers to the severe conjunctivitis several patients presented with, some of whom progressed to frank subconjunctival hemorrhage.

All patients with these symptoms died, resulting in an infinite OR.